CD274 and non-small cell lung carcinoma: Among the 54 patients enrolled in this study with advanced or postoperative recurrent NSCLC with low (1–49%) or negative (< 1%) PD-L1 expression, the median age was 72.5 years (range: 33.0–85.0).